Immediate Workup for Anemia in CKD Stage 3b
In this patient with eGFR 55 mL/min/1.73 m² (CKD Stage 3b) and mildly low RBC count, immediately obtain a complete anemia workup including hemoglobin, reticulocyte count, serum ferritin, transferrin saturation (TSAT), and serum vitamin B12/folate levels to determine if this represents early CKD-related anemia requiring intervention 1.
Why This Matters
Your patient has moderate chronic kidney disease (eGFR 55 indicates CKD Stage 3b), which puts them at significant risk for anemia-related complications. Anemia develops early in CKD and is associated with increased cardiovascular disease, hospitalization, and mortality 2. The fact that you're seeing a low RBC count now means you need to act before it progresses further.
The Diagnostic Algorithm
Step 1: Confirm True Anemia
- Obtain hemoglobin level immediately
- Anemia is defined as Hb <12 g/dL in men or postmenopausal women, or <11 g/dL in premenopausal women 2
- The low RBC count you're seeing suggests this is likely present
Step 2: Complete the KDIGO-Recommended Panel 1
Obtain these specific tests:
- Complete blood count with red cell indices and differential
- Absolute reticulocyte count (to assess bone marrow response)
- Serum ferritin (target >100 ng/mL for adequate iron stores)
- Transferrin saturation (TSAT) (target >20%)
- Serum vitamin B12 and folate levels (to exclude nutritional deficiencies)
Step 3: Interpret Iron Studies for Treatment Decisions
If ferritin <500 ng/mL AND TSAT <30%, initiate iron therapy 1:
- For CKD non-dialysis patients: trial of oral iron for 1-3 months OR intravenous iron
- IV iron is preferred if rapid correction needed or oral iron poorly tolerated
About That High MPV
The elevated mean platelet volume (9.65 fL) is not clinically significant in this context. While MPV has been studied as a prognostic marker in acute conditions like myocardial infarction 3 and COVID-19 4, it does not change your management approach here. Focus remains on the CKD and anemia workup.
Critical Pitfall to Avoid
The low platelet count reading could represent pseudothrombocytopenia from EDTA-induced platelet clumping 5. If platelet count appears low on your CBC, examine a peripheral blood smear immediately to confirm true thrombocytopenia versus artifact before pursuing unnecessary workup.
Risk Stratification
With eGFR 55 mL/min/1.73 m², this patient has independent risk factors for cardiovascular mortality and progression to end-stage kidney disease 6. The blood pressure target should be ≤130/80 mmHg, and if the patient has albuminuria, an ACE inhibitor or ARB is preferred 6.
When to Refer to Nephrology
Consider referral if:
- Anemia confirmed and requires erythropoiesis-stimulating agent (ESA) therapy
- eGFR continues declining
- Albuminuria is present (check urine albumin-to-creatinine ratio if not already done)
- Patient develops complications of CKD
Medication Safety Alert
With eGFR <60 mL/min/1.73 m², review all current medications for necessary dose adjustments and avoid nephrotoxic agents 6. Inform the pharmacist of the eGFR for appropriate dosing guidance.